Targeted Fat Metabolism Unlike systemic weight loss agents, AOD-9604 works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) specifically in the areas where its applied, allowing for precise body contouring
Theoretical considerations include: Potential interactions requiring monitoring: Other fat-loss agents or thermogenics (additive effects), growth hormone or growth hormone secretagogues (mechanism overlap), medications affecting glucose metabolism (monitor blood sugar despite AOD-9604s neutral glycemic effects)
Case presentation Case 1 A 17-year-old female presented with the complaints of weakness, fatigue and difficulty in breathing
GLOW Mix Peptide Therapy Combines multiple peptides to support recovery, reduce inflammation, and improve mobility and skin appearance
Individuals should contact their GP or a relevant specialist before considering retatrutide if they have any of the following: A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2): Rodent studies with GLP-1 receptor agonists have identified thyroid C-cell changes
However, translating elevated GH levels to measurable body composition changes in healthy individuals remains an open question